There is already some unconfirmed speculation that Bausch & Lomb may be up for sale now, with Novartis/Ciba Vision and Allergan as the most likely suitors. B&L a few days ago that it will eliminate an additional 350 jobs, representing more than 6.5 percent of its remaining workforce. In its ...
Buying a membership today will give you:
To continue reading this article register now.